WallStreetZenWallStreetZen

NASDAQ: AVTX
Avalo Therapeutics Inc Stock Ownership - Who owns Avalo Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Avalo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Garry Arthur NeilChief Executive Officer2025-03-2817,787$8.46
$150.48kSell
Christopher Ryan SullivanChief Financial Officer2025-03-287,285$8.46
$61.63kSell
June Sherie AlmenoffDirector2024-11-13500$13.00
$6.50kBuy
June Sherie AlmenoffDirector2024-11-12500$12.50
$6.25kBuy

1 of 1

AVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVTX insiders and whales buy or sell their stock.

AVTX Shareholders

What type of owners hold Avalo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC392.44%51,615,185$523.38MInsider
Robert Moscato Jr.68.07%8,952,643$90.78MInsider
Randal Jones48.36%6,359,900$64.49MInsider
Steven Boyd17.83%2,345,714$23.79MInsider
Patrick J. Crutcher12.43%1,634,771$16.58MInsider
Bvf Inc7.82%1,028,049$10.42MInstitution
Nantahala Capital Management LLC7.57%995,000$10.09MInstitution
Orbimed Advisors LLC7.35%967,000$9.81MInstitution
Ra Capital Management LP7.09%932,973$9.46MInstitution
Affinity Asset Advisors LLC4.62%607,872$6.16MInstitution

1 of 3

AVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVTX8.80%91.20%Net Selling
CGEN16.19%0.00%
ZURA45.32%54.68%Net Selling
PYXS44.27%37.65%Net Buying
CRBP41.55%58.45%Net Buying
View Top Biotech Stocks

Avalo Therapeutics Stock Ownership FAQ

Who owns Avalo Therapeutics?

Avalo Therapeutics (NASDAQ: AVTX) is owned by 59.63% institutional shareholders, 617.78% Avalo Therapeutics insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Avalo Therapeutics shareholder, owning 51.62M shares representing 392.44% of the company. Armistice Capital LLC's Avalo Therapeutics shares are currently valued at $503.76M.

If you're new to stock investing, here's how to buy Avalo Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.